Pharmaceutical Patent Litigation (CANCELLED) (LAW-795BC-E001)
Sanya Sukduang, Jonathan Davies
The dates have been finalized but the times need to be confirmed. This course will be a combination of live sessions and asynchronous materials/assignments. The block of time listed here will be the maximum amount of live session meeting time expected of you and maybe decreased to the extent of asynchronous material added.
This course provides a detailed look into a very complex area of patent litigation. This course will explore the origins of Hatch-Waxman and address various issues that arise litigating these cases, including FDA Orange Book patent listing and delisting, the interplay between patent law and FDA law as it pertains to branded drug exclusivity, settling Hatch-Waxman lawsuits, and the newly enacted counterpart to Hatch-Waxman, the Biologics Price, Competition, and Innovation Act for biological drugs. The course will use letter grades.
Textbooks and Other Materials
The textbook information on this page was provided by the instructor. Students should use this information when considering purchases from the AU Campus Store or other vendors. Students may check to determine if books are currently available for purchase online.
First Class Readings
Not available at this time.